COVID-19 Immunity Cross-Neutralized Bat Viruses
Researchers found that antibodies from people who recovered from COVID-19 can also neutralize some related animal coronaviruses.
Updated on Oct. 1, 2026 in Diseases — General
Live Poll
Do you trust that your previous COVID-19 infection protects you against potential future coronavirus outbreaks?
A study published in PLOS Biology suggests that immunity gained from SARS-CoV-2 infection offers cross-neutralization against certain sarbecoviruses found in animals. This finding helps clarify the potential for cross-species viral transmission.
Why it matters
Understanding how these viruses interact with ACE2 receptors is crucial for identifying which animal pathogens could potentially jump to humans. This research supports the development of broader strategies for future pandemic preparedness.
In a study analyzing interactions between 15 bat sarbecovirus spike proteins and ACE2 receptors from 34 species, researchers found that COVID-19 antibodies neutralize closely related viruses. Neutralization was notably weaker against more distant sarbecoviruses.
The players
The Pirbright Institute
A world-leading center of excellence in animal virus research and disease control.
King's College London
A prestigious research university contributing to global advancements in biomedical science.
The details
The researchers compared how spike proteins from different sarbecoviruses use ACE2 receptors to enter host cells across a library of 34 species. They identified that while viruses like SARS-CoV-2 and those from Laos (BANAL viruses) act as generalists capable of infecting multiple species, others like the UK-based RhGB07 are specialists with restricted receptor usage. This divergence suggests different evolutionary pressures on how these viruses bind to host cells.
Timeline
October 1, 2026: The research findings were published in PLOS Biology.
Health Landscape
This study advances the field by mapping the receptor-binding profiles of diverse sarbecoviruses to determine their pandemic potential. It updates our current understanding of sarbecovirus evolutionary biology by defining the limits of cross-reactivity for human-derived antibodies.
This research is currently focused on laboratory analysis and does not change existing guidance for personal health management or vaccination. Questions about immune protection remain best addressed through a conversation with your physician regarding your personal health status.
The takeaway
While antibodies from COVID-19 recovery provide some protection against related animal viruses, this cross-reactivity is limited by the genetic distance between the viruses. Stay informed on public health guidance regarding emerging respiratory threats as further research develops.
Further reading
For more on the mechanisms of viral immunity, explore the Diseases — General section.
Live Poll
Do you trust that your previous COVID-19 infection protects you against potential future coronavirus outbreaks?
